Attached files

file filename
EX-99.4 - EXHIBIT 99.4 - DermTech, Inc.v468611_ex99-4.htm
EX-99.3 - EXHIBIT 99.3 - DermTech, Inc.v468611_ex99-3.htm
EX-99.2 - EXHIBIT 99.2 - DermTech, Inc.v468611_ex99-2.htm
EX-99.1 - EXHIBIT 99.1 - DermTech, Inc.v468611_ex99-1.htm
EX-23.1 - EXHIBIT 23.1 - DermTech, Inc.v468611_ex23-1.htm
EX-14 - EXHIBIT 14 - DermTech, Inc.v468611_ex14.htm
EX-10.8 - EXHIBIT 10.8 - DermTech, Inc.v468611_ex10-8.htm
EX-10.7 - EXHIBIT 10.7 - DermTech, Inc.v468611_ex10-7.htm
EX-10.3 - EXHIBIT 10.3 - DermTech, Inc.v468611_ex10-3.htm
EX-4.6 - EXHIBIT 4.6 - DermTech, Inc.v468611_ex4-6.htm
EX-4.3 - EXHIBIT 4.3 - DermTech, Inc.v468611_ex4-3.htm
EX-4.2 - EXHIBIT 4.2 - DermTech, Inc.v468611_ex4-2.htm
EX-4.1 - EXHIBIT 4.1 - DermTech, Inc.v468611_ex4-1.htm
S-1/A - S-1/A - DermTech, Inc.v468611_s1a.htm

 

Exhibit 99.5

 

Consent OF KEWAL HANDA

 

As required by Rule 438 under the Securities Act of 1933, as amended, the undersigned hereby consents to being named as a Director Nominee in the Registration Statement on Form S-1 of Constellation Alpha Capital Corp. (the “Company”), originally filed on May 18, 2017, and any and all amendments thereto, registering securities for issuance in the Company’s initial public offering.

 

Dated: June 8, 2017

 

  /s/ Kewal Handa
  Kewal Handa